Physician profile
Sonia K Gill
NPI 1295120293
$8,079.01
in general payments reported to CMS, 2019-2025
35 companies · $1,679 in 2025
The $1,679 reported for 2025 was more than what a typical Clinical Neurophysiology provider received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2021: $137 · 2022: $1,087 · 2023: $2,857 · 2024: $2,201 · 2025: $1,679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,720 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,720.15 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $2,797.63 | 2022-2025 | Fintepla, Briviact, Nayzilam |
| Abbvie INC. | $1,173.06 | 2022-2025 | |
| Sk Life Science, INC. | $850.06 | 2022-2025 | Xcopri |
| Medtronic, INC. | $428.51 | 2023-2025 | Percept Pc Brainsense |
| Neurelis, INC. | $307.39 | 2023-2025 | Valtoco |
| Catalyst Pharmaceuticals, INC. | $281.61 | 2023-2024 | Fycompa |
| Lilly USA, LLC | $215.12 | 2022-2025 | Emgality, Amyvid, Reyvow |
| Eisai INC. | $187.21 | 2022-2025 | |
| Merz Pharmaceuticals, LLC | $186.03 | 2022-2024 | Xeomin |
| Jazz Pharmaceuticals INC. | $185.63 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $123.42 | 2023-2024 | Aptiom |
| Kyowa Kirin, INC. | $118.89 | 2021-2024 | Nourianz |
| Amgen INC. | $118.85 | 2019 | |
| Neuropace, INC. | $107.50 | 2022 | |
| Harmony Biosciences LLC | $104.48 | 2022-2023 | Wakix |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $92.32 | 2022 | |
| Aucta Pharmaceuticals, INC. | $79.70 | 2024 | Motpoly Xr |
| Livanova USA, INC. | $78.29 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Acorda Therapeutics, INC | $75.00 | 2021-2023 | Inbrija, Ampyra |
| Amneal Pharmaceuticals LLC | $68.27 | 2021-2024 | Rytary |
| Teva Pharmaceuticals USA, INC. | $57.09 | 2021-2023 | Austedo |
| Lundbeck LLC | $52.28 | 2023 | Vyepti |
| Adamas Pharmaceuticals, INC. | $44.05 | 2021 | |
| Avion Pharmaceuticals | $43.09 | 2022 | |
| Sunovion Pharmaceuticals INC. | $42.17 | 2022 | |
| Corium, LLC | $40.49 | 2023 | Adlarity |
| Insightec,INC | $33.35 | 2023-2024 | Exablate |
| Ge Healthcare | $31.40 | 2023-2024 | |
| Axsome Therapeutics, INC. | $29.61 | 2025 | Symbravo |
| Pfizer INC. | $29.49 | 2023 | |
| Biogen, INC. | $26.61 | 2025 | Leqembi |
| Avadel Cns Pharmaceuticals, LLC | $23.82 | 2023 | Lumryz |
| Otsuka America Pharmaceutical, INC. | $21.25 | 2023 | Nuedexta |
| Avanir Pharmaceuticals, INC. | $13.47 | 2022 | |
| Celgene Corporation | $11.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.